Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 114 articles: HTML format Text format

Single Articles

March 2010
1. AGELOPOULOS K , Greve B, Schmidt H, Pospisil H, et al
   Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.
   BMC Cancer. 2010;10:78.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. TOI M , Sperinde J, Huang W, Saji S, et al
   Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer.
   BMC Cancer. 2010;10:56.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. GARCIA-CASADO Z , Guerrero-Zotano A, Llombart-Cussac A, Calatrava A, et al
   A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.
   BMC Cancer. 2010;10:36.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. REDANA S , Donadio M, Nole F, Jacomuzzi ME, et al
   Trastuzumab with either docetaxel or vinorelbine as first-line treatment for patients with HER2-positive advanced breast cancer: a retrospective comparison.
   BMC Cancer. 2010;10:28.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. RAMOS EA , Camargo AA, Braun K, Slowik R, et al
   Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
   BMC Cancer. 2010;10:23.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. TSUJI K , Kawauchi S, Saito S, Furuya T, et al
   Breast cancer cell lines carry cell line-specific genomic alterations that are distinct from aberrations in breast cancer tissues: Comparison of the CGH profiles between cancer cell lines and primary cancer tissues.
   BMC Cancer. 2010;10:15.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. CURTIS CD , Thorngren DL, Nardulli AM
   Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary tissue and breast cancer tumors.
   BMC Cancer. 2010;10:9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. FERNANDEZ-GUINEA O , Andicoechea A, Gonzalez LO, Gonzalez-Reyes S, et al
   Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer.
   BMC Cancer. 2010;10:8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. HUOBER J , Fett W, Nusch A, Neise M, et al
   A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer.
   BMC Cancer. 2010;10:2.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
10. MORALES J , Alpaugh ML
    Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis.
    BMC Cancer. 2009;9:462.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. HAANPAA M , Reiman M, Nikkila J, Erkko H, et al
    Mutation analysis of the AATF gene in breast cancer families.
    BMC Cancer. 2009;9:457.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. XIA P , An HX, Dang CX, Radpour R, et al
    Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer.
    BMC Cancer. 2009;9:454.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. HARTMAIER RJ , Tchatchou S, Richter AS, Wang J, et al
    Nuclear receptor coregulator SNP discovery and impact on breast cancer risk.
    BMC Cancer. 2009;9:438.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
14. DAHL E , En-Nia A, Wiesmann F, Krings R, et al
    Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.
    BMC Cancer. 2009;9:410.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. DE CECCO L , Musella V, Veneroni S, Cappelletti V, et al
    Impact of biospecimens handling on biomarker research in breast cancer.
    BMC Cancer. 2009;9:409.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ZHANG J , Zhang M, Jiang W, Wang L, et al
    B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population.
    BMC Cancer. 2009;9:394.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. PROVATOPOULOU X , Gounaris A, Kalogera E, Zagouri F, et al
    Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their compex MMP-9/NGAL in breast cancer disease.
    BMC Cancer. 2009;9:390.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
18. SADJADI A , Hislop TG, Bajdik C, Bashash M, et al
    Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada.
    BMC Cancer. 2009;9:381.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HUANG O , Chen C, Wu J, Chen S, et al
    Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months.
    BMC Cancer. 2009;9:375.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. BARTSCH R , De Vries C, Pluschnig U, Dubsky P, et al
    Predicting for activity of second-line trastuzumab-based therapy in Her2-positive advanced breast cancer.
    BMC Cancer. 2009;9:367.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. YU XQ
    Socioeconomic disparities in breast cancer survival: relation to stage at diagnosis, treatment and race.
    BMC Cancer. 2009;9:364.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. XIAO Y , Gao X, Taratula O, Treado S, et al
    Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells.
    BMC Cancer. 2009;9:351.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. PETERS TM , Moore SC, Gierach GL, Wareham NJ, et al
    Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP Diet and Health Study.
    BMC Cancer. 2009;9:349.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
24. CONDE J , Silva SN, Azevedo AP, Teixeira V, et al
    Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.
    BMC Cancer. 2009;9:344.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LIN Y , Yin W, Yan T, Zhou L, et al
    Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients.
    BMC Cancer. 2009;9:342.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. ARDAVANIS A , Doufexis D, Kountourakis P, Malliou S, et al
    Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks. A retrospective case review study.
    BMC Cancer. 2009;9:338.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. NOTHACKER M , Duda V, Hahn M, Warm M, et al
    Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review.
    BMC Cancer. 2009;9:335.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. RUE M , Vilaprinyo E, Lee S, Martinez-Alonso M, et al
    Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain).
    BMC Cancer. 2009;9:326.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. SCHROHL AS , Look MP, Meijer-van Gelder ME, Foekens JA, et al
    Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study.
    BMC Cancer. 2009;9:322.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HADAD SM , Baker L, Quinlan PR, Robertson KE, et al
    Histological evaluation of AMPK signalling in primary breast cancer.
    BMC Cancer. 2009;9:307.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
31. TEN HAAF A , Bektas N, von Serenyi S, Losen I, et al
    Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.
    BMC Cancer. 2009;9:298.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. AL SARAKBI W , Sasi W, Jiang WG, Roberts T, et al
    The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters.
    BMC Cancer. 2009;9:290.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. ASHTON-PROLLA P , Giacomazzi J, Schmidt AV, Roth FL, et al
    Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
    BMC Cancer. 2009;9:283.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. GOLUBOVSKAYA VM , Zheng M, Zhang L, Li JL, et al
    The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAKsiRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
    BMC Cancer. 2009;9:280.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. AILAN H , Xiangwen X, Daolong R, Lu G, et al
    Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.
    BMC Cancer. 2009;9:279.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. MAJOR PP , Cook RJ, Lipton A, Smith MR, et al
    Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
    BMC Cancer. 2009;9:272.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
37. KHAITAN D , Sankpal UT, Weksler B, Meister EA, et al
    Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.
    BMC Cancer. 2009;9:258.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. CANZIAN F , Kaaks R, Cox DG, Henderson KD, et al
    Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    BMC Cancer. 2009;9:257.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. POVOSKI SP , Jimenez RE, Wang WP, Xu RX, et al
    Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancer.
    BMC Cancer. 2009;9:254.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. PALOMBA G , Loi A, Uras A, Fancello P, et al
    A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population.
    BMC Cancer. 2009;9:245.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. BUECHLER S
    Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer.
    BMC Cancer. 2009;9:243.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. RIAZ M , Elstrodt F, Hollestelle A, Dehghan A, et al
    Low-risk susceptibility alleles in 40 human breast cancer cell lines.
    BMC Cancer. 2009;9:236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. MANSFIELD AS , Heikkila PS, Vaara AT, von Smitten KA, et al
    Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer.
    BMC Cancer. 2009;9:231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. VERJANS E , Noetzel E, Bektas N, Schutz AK, et al
    Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
    BMC Cancer. 2009;9:230.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. WANG L , Jiang Z, Sui M, Shen J, et al
    The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens.
    BMC Cancer. 2009;9:226.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. ALAWADI SA , Ohaeri JU
    Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire.
    BMC Cancer. 2009;9:222.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. YASUOKA H , Kodama R, Tsujimoto M, Yoshidome K, et al
    Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.
    BMC Cancer. 2009;9:220.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. VEECK J , Wild PJ, Fuchs T, Schuffler PJ, et al
    Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
    BMC Cancer. 2009;9:217.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
49. KIM J , Lim SY, Shin A, Sung MK, et al
    Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study.
    BMC Cancer. 2009;9:216.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. MOSLEY JD , Keri RA
    Intrinsic bias in breast cancer gene expression data sets.
    BMC Cancer. 2009;9:214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. AKHIGBE AO , Omuemu VO
    Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city.
    BMC Cancer. 2009;9:203.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. CHARAFE-JAUFFRET E , Ginestier C, Birnbaum D
    Breast cancer stem cells: tools and models one can rely on.
    BMC Cancer. 2009;9:202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. JORISZEN H , Bektas N, Dahl E, Hartmann A, et al
    Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer.
    BMC Cancer. 2009;9:200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. KOHRMANN A , Kammerer U, Kapp M, Dietl J, et al
    Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.
    BMC Cancer. 2009;9:188.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. LYKKESFELDT AE , Henriksen KL, Rasmussen BB, Sasano H, et al
    In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.
    BMC Cancer. 2009;9:185.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. DESJARDINS S , Joly Beauparlant C, Labrie Y, Ouellette G, et al
    Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.
    BMC Cancer. 2009;9:181.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. KOOP EA , van Laar T, van Wichen DF, de Weger RA, et al
    Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features.
    BMC Cancer. 2009;9:175.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. REZAIANZADEH A , Peacock J, Reidpath D, Talei A, et al
    Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.
    BMC Cancer. 2009;9:168.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
59. JESNECK JL , Mukherjee S, Yurkovetsky Z, Clyde M, et al
    Do serum biomarkers really measure breast cancer?
    BMC Cancer. 2009;9:164.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. PARK IH , Ro J, Nam BH, Kwon Y, et al
    Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases.
    BMC Cancer. 2009;9:154.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. DONG X , Liu A, Zer C, Feng J, et al
    siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.
    BMC Cancer. 2009;9:133.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
62. MA E , Iwasaki M, Ishihara J, Hamada GS, et al
    Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women.
    BMC Cancer. 2009;9:122.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. HOVING JL , Broekhuizen ML, Frings Dresen MH
    Return to work of breast cancer survivors: a systematic review of intervention studies.
    BMC Cancer. 2009;9:117.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. ANTOGNELLI C , Del Buono C, Ludovini V, Gori S, et al
    CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
    BMC Cancer. 2009;9:115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. BRITTO AV , Schenka AA, Moraes-Schenka NG, Alvarenga M, et al
    Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer.
    BMC Cancer. 2009;9:109.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. HOFFMANN J , Wallwiener D
    Classifying breast cancer surgery: a novel, complexity-based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients.
    BMC Cancer. 2009;9:108.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. TIKOO K , Kumar P, Gupta J
    Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
    BMC Cancer. 2009;9:107.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. NIEDER C , Marienhagen K, Astner ST, Molls M, et al
    Prognostic scores in brain metastases from breast cancer.
    BMC Cancer. 2009;9:105.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. HENNEGES C , Bullinger D, Fux R, Friese N, et al
    Prediction of breast cancer by profiling of urinary RNA metabolites using SVM-based feature selection.
    BMC Cancer. 2009;9:104.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. AKKIPRIK M , Hu L, Sahin A, Hao X, et al
    The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.
    BMC Cancer. 2009;9:103.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. CAI D , Cao J, Li Z, Zheng X, et al
    Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
    BMC Cancer. 2009;9:102.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
72. VILAPRINYO E , Rue M, Marcos-Gragera R, Martinez-Alonso M, et al
    Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data.
    BMC Cancer. 2009;9:98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. CASTELLO-CROS R , Khan DR, Simons J, Valianou M, et al
    Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.
    BMC Cancer. 2009;9:94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. YOUNG SR , Pilarski RT, Donenberg T, Shapiro C, et al
    The Prevalence of BRCA Mutations Among Young Women with Triple-Negative Breast Cancer.
    BMC Cancer. 2009;9:86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. LACEY JV JR , Kreimer AR, Buys SS, Marcus PM, et al
    Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    BMC Cancer. 2009;9:84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. GRIMM C , Kantelhardt E, Heinze G, Polterauer S, et al
    The prognostic value of four interleukin-1 gene polymorphisms in caucasian women with breast cancer - a multicenter study.
    BMC Cancer. 2009;9:78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. IBRAHIM NA , Odusanya OO
    Knowledge of risk factors, beliefs and practices of female healthcare professionals towards breast cancer in a tertiary hospital in Lagos, Nigeria.
    BMC Cancer. 2009;9:76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. SARRIO D , Palacios J, Hergueta-Redondo M, Gomez-Lopez G, et al
    Functional characterization of E- and P-cadherin in invasive breast cancer cells.
    BMC Cancer. 2009;9:74.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
79. JOHANSSON D , Kosovac E, Moharer J, Ljuslinder I, et al
    Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis.
    BMC Cancer. 2009;9:67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. BUDRONI M , Cesaraccio R, Coviello V, Sechi O, et al
    Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia.
    BMC Cancer. 2009;9:62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. NECHUSHTAN H , Hamburger T, Mendelson S, Kadouri L, et al
    Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations.
    BMC Cancer. 2009;9:60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. VISIGALLI D , Palmieri D, Strangio A, Astigiano S, et al
    The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts.
    BMC Cancer. 2009;9:59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. HA SA , Shin S, Kim H, Kim S, et al
    Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 level, p53 mutation, and ER/PR expression.
    BMC Cancer. 2009;9:51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. CANTU DE LEON D , Perez Montiel D, Villavicencio V, Garcia Carranca A, et al
    High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.
    BMC Cancer. 2009;9:48.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
85. HAIMAN CA , Garcia RR, Hsu C, Xia L, et al
    Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
    BMC Cancer. 2009;9:43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. KODURU S , Srinivasan S, Kumar R, Gomathinayagam R, et al
    Identification of a potent herbal molecule for the treatment of breast cancer.
    BMC Cancer. 2009;9:41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. KNIGHT LA , Kurbacher CM, Glaysher S, Fernando A, et al
    Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
    BMC Cancer. 2009;9:38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. TAN H , Zhong Y, Pan Z
    Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
    BMC Cancer. 2009;9:31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. CANTU DE LEON D , Perez Montiel D, Nemcova J, Mikyskova I, et al
    Human Papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients.
    BMC Cancer. 2009;9:26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. FIGUEIRA RC , Gomes LR, Neto JS, Silva FC, et al
    Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
    BMC Cancer. 2009;9:20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. COTRONEO MS , Haag JD, Stapel NR, Waller JL, et al
    Freund's vaccine adjuvant promotes Her2/Neu breast cancer.
    BMC Cancer. 2009;9:19.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. SUN YF , Leu JD, Chen SM, Lin IF, et al
    Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer.
    BMC Cancer. 2009;9:13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. RETSKY MW , Hrushesky WJ, Gukas ID
    Hypothesis: primary antiangiogenic method proposed to treat early stage breast cancer.
    BMC Cancer. 2009;9:7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. YILI Z , Xiaoyan H, Hongwen D, Yun Z, et al
    The value of diffusion-weighted imaging in assessing the ADC changes of tissues adjacent to breast carcinoma.
    BMC Cancer. 2009;9:18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SCHILLER KR , Zillhardt MR, Alley J, Borjesson DL, et al
    Secretion of MCP-1 and other paracrine factors in a novel tumor-bone coculture model.
    BMC Cancer. 2009;9:45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. SENISKI GG , Camargo AA, Ierardi DF, Ramos EA, et al
    ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.
    BMC Cancer. 2009;9:80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MENG Y , Gu C, Wu Z, Zhao Y, et al
    Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
    BMC Cancer. 2009;9:75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. BELKORA JK , Rugo HS, Moore DH, Hutton DW, et al
    Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis.
    BMC Cancer. 2009;9:127.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. YANG X , Lazar IM
    MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptides.
    BMC Cancer. 2009;9:96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. ROSA FE , Silveira SM, Silveira CG, Bergamo NA, et al
     Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma.
     BMC Cancer. 2009;9:90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. QI L , Bart J, Tan LP, Platteel I, et al
     Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma.
     BMC Cancer. 2009;9:163.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. LIN C , Chien SY, Chen LS, Kuo SJ, et al
     Triple negative breast carcinoma is a prognostic factor in Taiwanese women.
     BMC Cancer. 2009;9:192.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. TURASHVILI G , Leung S, Turbin D, Montgomery K, et al
     Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis.
     BMC Cancer. 2009;9:165.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. WONG PS , Li W, Vogel CF, Matsumura F, et al
     Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR).
     BMC Cancer. 2009;9:234.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. HSIEH SM , Smith RA, Lintell NA, Hunter KW, et al
     Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
     BMC Cancer. 2009;9:331.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. PRASAD CP , Rath G, Mathur S, Bhatnagar D, et al
     Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.
     BMC Cancer. 2009;9:325.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
107. PYLKAS K , Erkko H, Nikkila J, Slyom S, et al
     Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families.
     BMC Cancer. 2008;8:146.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     
108. MACHACKOVA E , Foretova L, Lukesova M, Vasickova P, et al
     Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.
     BMC Cancer. 2008;8:140.
     PubMed     Text format     Related articles    Abstract available   Free Full Text
     
     
     January 2008
109. MENENDEZ JA , Vazquez-Martin A, Garcia-Villalba R, Carrasco-Pancorbo A, et al
     tabAnti-HER2 (erbB-2) oncogene effects of phenolic compounds directly isolated from commercial Extra-Virgin Olive Oil (EVOO).
     BMC Cancer. 2008;8:377.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. SONNENBERG M , van der Kuip H, Haubeis S, Fritz P, et al
     Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.
     BMC Cancer. 2008;8:364.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. RUE M , Carles M, Vilaprinyo E, Martinez-Alonso M, et al
     Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain).
     BMC Cancer. 2008;8:336.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. TOYAMA T , Yamashita H, Kondo N, Okuda K, et al
     Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
     BMC Cancer. 2008;8:309.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. YANG R , Li WW, Hoang BH, Kim H, et al
     Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier.
     BMC Cancer. 2008;8:124.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. LITWINIUK MM , Roznowski K, Filas V, Godlewski DD, et al
     Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
     BMC Cancer. 2008;8:100.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: